CG Dimono PTx is a dermal filler developed by Caregen, a South Korean biotechnology company. It was launched in 2023 and is marketed as the world’s first Type C BTX peptide.

CG Dimono PTx is a combination product containing both hyaluronic acid and a peptide complex. It is a safe and effective alternative to traditional dermal fillers and botulinum toxin injections.

Manufactured by Caregen, CG Dimono PTx is part of a renowned product lineup that includes popular brands such as Dr. CYJ Hair Filler, Aquashine, and Dermaheal, among others.